Improved outlook for immune-based therapies

Assay identifies T cells most capable of fighting infections and cancers

2013-07-04

(Press-News.org) The idea of fighting infections and even cancers by inducing protective immune responses may now be a step closer to clinical practice. Researchers have removed a major obstacle to widespread use of so-called adoptive transfer therapy, in which a patient receives "killer" immune cells targeting a disease agent. Existing technologies can easily provide T cells that will recognize a specific antigen, but it has been challenging to identify individual cells most likely to succeed in fighting the disease – until now.

Scientists at the Technische Universitaet Muenchen (TUM) have developed the first assay for living T cells that can quantify how strongly the cells' receptors bind to their targeted antigen. Optimal binding strength or "structural avidity" is thought to be the most important predictor of success in adoptive transfer therapies. Together with collaborators in Seattle, Mainz, and Berlin, the TUM researchers have successfully tested their assay in preclinical animal models very close to clinical settings and with human T cells. They published their results in the journal Science Translational Medicine.

A new key to predictability

There are countless kinds of T cells, each one expressing a single type of receptor -- a surface structure capable of locking onto a particular ligand molecule that may, for example, be associated with a virus or a tumor. If a patient's immune system cannot mount an effective defense, it may be possible to fight the disease by introducing the right kind of T cell, either prepared from the patient's own cells or obtained from a donor.

But in a population of T cells equipped to recognize a particular antigen, individual T cells can vary greatly in structural avidity. A main determinant of a T cell's binding strength is the so-called "off rate" -- simply put, a slower off rate indicates stronger binding -- which thus predicts its likely fitness for use in adoptive transfer therapy. And that is what the TUM assay measures, directly and precisely.

The TUM technology offers three marked advantages over previous methods: It is (relatively) simple; it can be used on the surface of living T cells without harming or changing them; and it gives, for the first time, a quantitative measure of binding strength. "This is a true value that we can repeat, and we can compare individual cells on the basis of these measurements," explains Prof. Dirk Busch, director of the TUM Institute for Medical Microbiology, Immunology, and Hygiene. "Furthermore, we now have been able to show that there is indeed a correlation between these values and what the cells can do when we put them into a clinically relevant setting."

Bridging the distance from the labs to the clinic

The Munich-based team had been working on this technology and the underlying scientific questions for nearly a decade before making one crucial connection -- to Seattle. With support from the TUM Institute for Advanced Study, a bridge was formed between Busch's labs and those of Prof. Stanley Riddell at the Fred Hutchinson Cancer Research Center, University of Washington.

A pioneer in cell-based therapy, Riddell had been looking for new ways to achieve higher quality and purity in cells for clinical use. Busch was seeking a partner with top-level expertise in human cell-therapy research, trials, and treatment. Together, they developed a close-knit collaboration across nine time zones that transformed both laboratories. Over the course of three years, Riddell spent months in Munich and hosted a number of Busch's postdocs and doctoral candidates, including some of the authors of the current paper, in Seattle. Weekly video conferences filled in the gaps.

As Busch describes it, though, the most significant gap they bridged was the distance from the labs to the clinic. "Stan taught us a lot about how to work with human T cells," he says, "and a lot of the data in this paper, in particular the data on human T cells, is a direct result of our TUM-IAS focus group on clinical cell processing and purification." He is optimistic about the prospects for the T-cell selection assay to play a role in clinical trials and ultimately in therapies, as well as in helping to address critical open questions about immune responses to major diseases.

"Immunotherapy is now beginning to have a major impact for patients with cancer and infectious diseases," Riddell says. "This work provides a novel approach for evaluating the qualities of T cells that may be used for cellular immunotherapy, and it facilitates the selection of those T cells that would be most effective in treating disease."

INFORMATION:

This research was supported by the German Research Foundation (DFG) through Collaborative Research Centers SFB TR36 (TP-B10/13), SFB 1054 (TP-B09), and SFB 490 (TP-E3), and through a DFG grant from the Clinical Research Group KFO 183 (individual project TP8), as well as by the TUM Institute for Advanced Study (Focus Group: Clinical Cell Processing and Purification).

Publication:

TCR-ligand k-off rate predicts protective capacity of antigen-specific CD8+ T cells for adoptive transfer. Magdalena Nauerth, Bianca Weissbrich, Robert Knall, Tobias Franz, Georg Doessinger, Jeanette Bet, Paulina J. Paszkiewicz, Lukas Pfeifer, Mario Bunse, Wolfgang Uckert, Rafaela Holtappels, Dorothea Gillert-Marien, Michael Neuenhahn, Angela Krackhardt, Matthias J. Reddehase, Stanley R. Riddell, and Dirk H. Busch. Science Translational Medicine 2013, vol. 5, issue 192. DOI: 10.1126/scitranslmed.3005958

Contact:

Prof. Dirk Busch
Institute for Medical Microbiology, Immunology, and Hygiene
Technische Universität München
T: +49 (0)89 4140-4120
E: dirk.busch@mikrobio.med.tum.de
W: http://www.mikrobio.med.tu-muenchen.de

Technische Universitaet Muenchen (TUM) is one of Europe's leading universities. It has roughly 500 professors, 9,000 academic and non-academic staff, and 32,000 students. It focuses on the engineering sciences, natural sciences, life sciences, medicine, and economic sciences. After winning numerous awards, it was selected as an "Excellence University" in 2006 and 2012 by the Science Council (Wissenschaftsrat) and the German Research Foundation (DFG). In both international and national rankings, TUM is rated as one of Germany's top universities. TUM is dedicated to the ideal of a top-level research-oriented entrepreneurial university. The university's global presence includes offices in Beijing (China), Brussels (Belgium), Cairo (Egypt) and Sao Paulo (Brazil). The German Institute of Science and Technology (GIST), founded in 2002 in Singapore, is the first research campus of a German university abroad. http://www.tum.de

ELSE PRESS RELEASES FROM THIS DATE:

Genetic signals reflect the evolutionary impact of cholera

2013-07-04

An international research team has used a novel approach to identify genetic factors that appear to influence susceptibility to cholera. The findings by investigators from Massachusetts General Hospital (MGH), the Broad Institute and the International Center for Diarrhœal Disease Research, Bangladesh (ICDDR,B) indicate the importance of pathways involved in regulating water loss in intestinal cells and of the innate immune system in the body's response to the bacteria that causes cholera, which affects from 3 to 5 million people each year and causes more than 100,000 deaths. ...

First comprehensive regulatory map is a blueprint for how to defeat tuberculosis

2013-07-04

Despite decades of research on the bacterium that causes tuberculosis (TB), scientists have not had a comprehensive understanding of how the bacterium is wired to adapt to changing conditions in the host. Now, researchers at Stanford University, Seattle BioMed, Boston University and the Broad Institute, Max Planck Institute of Biology in Berlin, Germany, Caprion Proteomics Inc. in Montreal, Canada, Brigham and Woman's Hospital (Harvard University), and Colorado State University have taken the first steps toward a complete representation of the regulatory network for Mycobacterium ...

Evidence suggests Antarctic crabs could be native

2013-07-04

A new study has cast doubt on the claim that crabs may have disappeared from Antarctica only to return due to warming seas. The theory surfaced two years ago following the discovery of a major colony of King crabs (Lithodidae) in the Palmer Deep, a basin in the continental shelf off the Antarctic Peninsula. It was thought the species may have left the continent between 40 and 15 million years ago and was returning as seawater temperatures rose. Fears were expressed that its reintroduction would decimate other fauna in the region. But an extensive study of all known ...

Cockatoos 'pick' puzzle box locks

2013-07-04

A species of Indonesian parrot can solve complex mechanical problems that involve undoing a series of locks one after another, revealing new depths to physical intelligence in birds. A team of scientists from Oxford University, the University of Vienna, and the Max Planck Institute, report in PLOS ONE a study in which ten untrained Goffin's cockatoos [Cacatua goffini] faced a puzzle box showing food (a nut) behind a transparent door secured by a series of five different interlocking devices, each one jamming the next along in the series. To retrieve the nut the birds ...

Animal master-burglars: Cockatoos show technical intelligence on a 5-lock problem

2013-07-04

Solving one problem in order to gain access to another, which will enable you to address a third problem (and so on) in order to finally reach a goal – so-called sequential problem solving – is considered to be cognitively highly challenging as it requires the ability to spatially and mentally distance oneself from a desired goal. In the study, ten untrained cockatoos faced a puzzle box showing a nut behind a transparent door closed by five different interlocking devices, each one jamming the next along the series and each required different motor actions in order to ...

Bacteria communicate to help each other resist antibiotics

2013-07-04

New research from Western University unravels a novel means of communication that allows bacteria such as Burkholderia cenocepacia (B. cenocepacia) to resist antibiotic treatment. B. cenocepacia is an environmental bacterium that causes devastating infections in patients with cystic fibrosis (CF) or with compromised immune systems. Dr. Miguel Valvano and first author Omar El-Halfawy, PhD candidate, show that the more antibiotic resistant cells within a bacterial population produce and share small molecules with less resistant cells, making them more resistant to antibiotic ...

Climate change deniers using dirty tricks from 'Tobacco Wars'

2013-07-04

Fossil fuel companies have been funding smear campaigns that raise doubts about climate change, writes John Sauven in the latest issue of Index on Censorship magazine. Environmental campaigner Sauven argues: "Some of the characters involved have previously worked to deny the reality of the hole in the ozone layer, acid rain and the link between tobacco and lung cancer. And the tactics they are applying are largely the same as those they used in the tobacco wars. Doubt is still their product." Governments around the world have also attempted to silence scientists who ...

Boston University study identifies molecular circuitry that helps tuberculosis survive for decades

2013-07-04

(Boston) – In a study from Boston University's National Emerging Infectious Diseases Laboratories (NEIDL), researchers have generated a map of the cellular circuitry of Mycobacterium tuberculosis, the causative agent of human tuberculosis (TB). This information, which is being published online as an Advanced Online Publication in the journal Nature, sheds new light on the bacterium's ability to survive inactive in the human body for decades, resist treatment and cause disease. M. tuberculosis can cause devastating infections of the lungs and other body sites. In 2011 ...

Key factors in understanding differences in rates of birth defects identified

2013-07-04

New research, published today in The Lancet, highlights important information for health professionals and parents about the factors which may increase the likelihood of a baby being born with a birth defect. The findings, from researchers at the Universities of Bradford and Leeds, funded by the National Institute for Health Research (NIHR), confirm that the two main factors associated with an increased risk of babies being born with a birth defect are being born to an older mother or to parents who are blood relations. In addition, the research team was also able to ...

Great ape genetic diversity catalog frames primate evolution and future conservation

2013-07-04

A model of great ape history over the past 15 million years has been fashioned through the study of genetic variation in a large panel of humans, chimpanzees, gorillas and orangutans. The catalog of great ape genetic diversity, the most comprehensive ever, elucidates the evolution and population histories of great apes from Africa and Indonesia. The resource will likely also aid in current and future conservation efforts which strive to preserve natural genetic diversity in populations. More than 75 scientists and wildlife conservationists from around the world assisted ...

Improved outlook for immune-based therapies

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: